{"id":1016563,"date":"2026-11-03T01:04:58","date_gmt":"2026-11-03T06:04:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/"},"modified":"2026-11-03T01:04:58","modified_gmt":"2026-11-03T06:04:58","slug":"argenx-to-present-at-upcoming-investor-conferences-9","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/","title":{"rendered":"argenx to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <b>November 3, 2026<\/b>\n      <\/p>\n<p align=\"justify\">\n        <b>Amsterdam, the Netherlands<\/b>\u00a0\u2013 argenx (Euronext &amp; Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor conferences in November:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <b>Guggenheim 3rd Annual Healthcare Innovation Conference<\/b>. Fireside chat on Tuesday, November 10 at 2:00 p.m. ET in Boston, MA.<\/li>\n<li style=\"text-align:justify\">\n          <b>Jefferies London Global Healthcare Conference<\/b>. Fireside chat on Tuesday, November 17 at 8:30 a.m. GMT in London, UK.<\/li>\n<\/ul>\n<p align=\"justify\">A live webcast of the presentations may be accessed on the Investors section of the argenx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mxi9xsnuVh3leX9TyEE-P5WmFmse9oQxLdykQdwXEcxF1FdRVD8-yGDQkyBHDoOa-YmX4gLokWxMRhm2lyKT8nQkhQ3E77OG-CapmSU8nNd2CjNmS58hkOOLx3SPsvueSMnAeIGH1rkJHzxKFiDKv-uxxSzD26XIyy_YIby_S2c36rBA3F3mr0IooWDQXfM2qgCUbcyn_YHs4f027x6jUXArP6xALU6VBFYTASBmwAAx4tQwWF6gWNAr8-atx-plUXCejCj76KttXqyWVXDdVGzbu7OI9sTiyar6btDi7-A=\" rel=\"nofollow\" target=\"_blank\">argenx.com\/investors<\/a>. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation.<\/p>\n<p align=\"justify\">\n        <b>About argenx<\/b><\/p>\n<p>argenx is the immunology innovation company, focused on turning immunology breakthroughs into medicines for patients. The company seeks novel biology wherever it emerges, co-creating with academic researchers through its Immunology Innovation Program (IIP) and investing in promising science, to develop treatments for people living with underserved diseases. By advancing molecules with the potential to reach multiple diseases and patient populations, argenx is building a world-class portfolio. This approach produced the first approved antibody fragment targeting the neonatal Fc receptor (FcRn) and today powers a growing pipeline of early and late-stage programs across several therapeutic areas. For more information, visit \u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cWS4fQpsuN3UjYnpyY2Jd6VcqGRB1ZvS1mCSScnFvPfahcWh1f05iN0FcMHxIz-9vJO0fxwTATEB5M7gIH7dmg==\" rel=\"nofollow\" target=\"_blank\">www.argenx.com\u00a0<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wew-R0_ZkfnGMycu_CQVjU0TonbII1mUVM8jXFoSZG2c1iTJo-rpA5JRn6J-AXJB_IMPXiEXniklrM95zI6G0gM6Fk6CU3XDca7MPHQPxsM=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2JcGYJz6b6Oj75wYavlE7J28T0ektnkurFmQo4zF_l03N8cKNeEf5qOHl98hd8gEmZwB5zz4ZTfWbQOt7py3Xm72XvxhuLLUHf9mUj6xpOo=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DLEsf2HFc5-IzdGAO0h14O75VTaWuQySkHqyEhLEbguw9jpULJ5V-vW5_rrPW6K7As8C051dyRSbLTwIMnPWICsOrDMq0vJuUIRdD5iNEmg=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XgSm-mtRz73AebsPPVzaMvlkQHbFiI6BrG0dOssKmWlTrdmRynBIxq_oebwr9hR0wp3d-KDfeiClAQiqmjBgaqi-cwUjst3-D2GH3RmCbr8=\" rel=\"nofollow\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p align=\"justify\">\n        <b>Contacts<\/b>\n      <\/p>\n<p align=\"justify\">\n        <b>Media:<\/b>\n      <\/p>\n<p align=\"justify\">Ben Petok<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2nex_DT5upbSO8ZLlws5AkmaTVD3rr7gQpqau6U7HNkMircSAJF4TsJwBGZR0-EJ21ne7VdbOqqMqmXoUrOPgV4mLqidBDRDXYeu2WKEptk=\" rel=\"nofollow\" target=\"_blank\">bpetok@argenx.com<\/a><\/p>\n<p align=\"justify\">\n        <b>Investors:<\/b>\n      <\/p>\n<p align=\"justify\">Alexandra Roy<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x7K0R9v2SxavF8VdS4qbdKNhN3_ecEGrNXB1mI8OY_5SG6J7M4GhrRzMCllrWlP0vRQHEvZRPRaTbJ4Kz2qFR27l_mWK0LG-sWgUA5q6ebQ=\" rel=\"nofollow\" target=\"_blank\">aroy@argenx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/OGMyMWU5ZDktNzQwYS00MzQ1LWJiZWMtZTQ3NzNkOGQ3MWQ4LTEwMTUzNDUtMjAyNi0xMS0wMy1lbg==\/tiny\/argenx-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>November 3, 2026 Amsterdam, the Netherlands\u00a0\u2013 argenx (Euronext &amp; Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference. Fireside chat on Tuesday, November 10 at 2:00 p.m. ET in Boston, MA. Jefferies London Global Healthcare Conference. Fireside chat on Tuesday, November 17 at 8:30 a.m. GMT in London, UK. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation. About argenx argenx is the immunology innovation company, focused on turning immunology breakthroughs &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;argenx to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016563","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>argenx to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"November 3, 2026 Amsterdam, the Netherlands\u00a0\u2013 argenx (Euronext &amp; Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference. Fireside chat on Tuesday, November 10 at 2:00 p.m. ET in Boston, MA. Jefferies London Global Healthcare Conference. Fireside chat on Tuesday, November 17 at 8:30 a.m. GMT in London, UK. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation. About argenx argenx is the immunology innovation company, focused on turning immunology breakthroughs &hellip; Continue reading &quot;argenx to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-03T06:04:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"argenx to Present at Upcoming Investor Conferences\",\"datePublished\":\"2026-11-03T06:04:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/\",\"name\":\"argenx to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\",\"datePublished\":\"2026-11-03T06:04:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-present-at-upcoming-investor-conferences-9\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/","og_locale":"en_US","og_type":"article","og_title":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"November 3, 2026 Amsterdam, the Netherlands\u00a0\u2013 argenx (Euronext &amp; Nasdaq: ARGX), the immunology innovation company, today announced that members of the management team will participate in the following investor conferences in November: Guggenheim 3rd Annual Healthcare Innovation Conference. Fireside chat on Tuesday, November 10 at 2:00 p.m. ET in Boston, MA. Jefferies London Global Healthcare Conference. Fireside chat on Tuesday, November 17 at 8:30 a.m. GMT in London, UK. A live webcast of the presentations may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation. About argenx argenx is the immunology innovation company, focused on turning immunology breakthroughs &hellip; Continue reading \"argenx to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-03T06:04:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"argenx to Present at Upcoming Investor Conferences","datePublished":"2026-11-03T06:04:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/","name":"argenx to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==","datePublished":"2026-11-03T06:04:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMTQwMSM0MDI1NTc1NDQjMjAwMzc3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-present-at-upcoming-investor-conferences-9\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"argenx to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016563"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016563\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}